Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Drug Discovery Today|October 26, 2005
Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug developmentSteven Whitebread, Jacques Hamon, Dejan Bojanic, et al.
Journal of Chemical Information and Modeling|February 9, 2007
Clustering and rule-based classifications of chemical structures evaluated in the biological activity spaceAnsgar Schuffenhauer, Nathan Brown, Peter Ertl, et al.
Future Medicinal Chemistry|March 24, 2011
In vitro safety pharmacology profiling: what else beyond hERG?Jacques Hamon, Steven Whitebread, Valerie Techer-Etienne, et al.
Nature Reviews. Drug Discovery|December 1, 2012
Reducing safety-related drug attrition: the use of in vitro pharmacological profilingJoanne Bowes, Andrew J Brown, Jacques Hamon, et al.
Angewandte Chemie (International Ed. in English)|December 6, 2014
Multidimensional de novo design reveals 5-HT2B receptor-selective ligandsTiago Rodrigues, Nadine Hauser, Daniel Reker, et al.
Chemmedchem|May 12, 2007
Modeling promiscuity based on in vitro safety pharmacology profiling dataKamal Azzaoui, Jacques Hamon, Bernard Faller, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 28, 2006
High-throughput in vitro profiling assays: lessons learnt from experiences at NovartisBernard Faller, Jianling Wang, Alfred Zimmerlin, et al.
The Journal of Biological Chemistry|March 21, 2006
Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effectsStefan Raduner, Adriana Majewska, Jian-Zhong Chen, et al.
Journal of Medicinal Chemistry|October 15, 2013
Efficient search of chemical space: navigating from fragments to structurally diverse chemotypesAnne Mai Wassermann, Peter S Kutchukian, Eugen Lounkine, et al.
Pageof 2